Edition:
United Kingdom

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

39.94USD
21 May 2019
Change (% chg)

-- (--)
Prev Close
$39.94
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
139,843
52-wk High
$46.12
52-wk Low
$18.00

About

Audentes Therapeutics, Inc. is an early-stage biotechnology company. The Company is focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects. The Company has a portfolio of product candidates, including AT132 for the... (more)

Overall

Beta: --
Market Cap(Mil.): $1,768.96
Shares Outstanding(Mil.): 44.29
Dividend: --
Yield (%): --

Financials

  BOLD.OQ Industry Sector
P/E (TTM): -- 93.91 35.38
EPS (TTM): -3.79 -- --
ROI: -38.84 7.62 11.72
ROE: -40.46 8.12 16.38

Earnings vs. Estimates